Cargando…

Role of Plasma methylated SEPT9 for Predicting Microvascular Invasion and Tumor Proliferation in Hepatocellular Carcinoma

Background: Methylated SEPT9 (mSEPT9) has a role in the occurrence and development of hepatocellular carcinoma (HCC). Here, we studied the significance of plasma mSEPT9 for predicting prognosis-associated pathological parameters in patients with HCC. Methods: We retrospectively analyzed data from 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Fei, Yang, Guowei, Jiang, Huiqin, Chen, Xinning, Yang, Yihui, Yu, Qian, Pan, Baishen, Wang, Beili, Guo, Wei, Yang, Wenjing, Zhang, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Screening, diagnosis, and treatment of hepatocellular carcinoma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806378/ https://www.ncbi.nlm.nih.gov/pubmed/36573042 http://dx.doi.org/10.1177/15330338221144510

Ejemplares similares

Recent Update on Immunotherapy and Its Combination With Interventional Therapies for Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Zhao, Dongxu, et al.
Publicado: (2023)

Effectiveness of c-TACE Combined With Sorafenib Versus c-TACE Monotherapy in Advanced Hepatocellular Carcinoma: A Retrospective Study
por: Liu, Shanshan, et al.
Publicado: (2023)

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation
por: Wan, Ping, et al.
Publicado: (2014)

Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2021)

Baseline characteristics associated with survival in patients with hepatocellular carcinoma
por: Aslanov, Seymur, et al.
Publicado: (2021)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2021)

Combination of molecularly targeted therapies and immune checkpoint inhibitors in the new era of unresectable hepatocellular carcinoma treatment
por: Liu, Ze-Long, et al.
Publicado: (2021)

Cervical Screening Practices and Outcomes for Young Women in Response to Changed Guidelines in Calgary, Canada, 2007–2016
por: Sayed, Sayeeda Amber, et al.
Publicado: (2020)

Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review
por: Bonde, Jesper, et al.
Publicado: (2020)

Predictors of Readmission After Pulmonary Resection in Patients With Lung Cancer: A Systematic Review and Meta-analysis
por: Liu, Jie, et al.
Publicado: (2022)

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population
por: Zhang, Yusi, et al.
Publicado: (2022)

Tubulin Alpha-1b as a Potential Biomarker for Lung Adenocarcinoma Diagnosis and Prognosis
por: Pang, Xue-Li, et al.
Publicado: (2023)

Systemic and Local Effects Among Patients With Betel Quid-Related Oral Cancer
por: Chuang, Hui-Ching, et al.
Publicado: (2022)

Advances in the Diagnosis and Treatment of a Driving Target: RET Rearrangements in non-Small-Cell Lung Cancer (NSCLC) Especially in China
por: Li, Tao, et al.
Publicado: (2023)

The Role of Myeloid-Derived Suppressor Cells in the Treatment of Pancreatic Cancer
por: Dong, Peng, et al.
Publicado: (2022)

The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma
por: Tsai, Ming-Hsien, et al.
Publicado: (2022)

Postoperative circulating tumor DNA testing based on tumor naïve strategy after liver metastasis surgery in colorectal cancer patients
por: Jiang, Huiqin, et al.
Publicado: (2023)

Estrogen Receptor Bio-Activities Determine Clinical Endocrine Treatment Options in Estrogen Receptor-Positive Breast Cancer
por: Xia, Song, et al.
Publicado: (2022)

Long-term Survival After Diverse Therapeutic Modalities in Malignant Phyllodes Tumors of the Breast
por: Zhang, Hongyi, et al.
Publicado: (2022)

Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC
por: Wang, Hao, et al.
Publicado: (2022)

Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study
por: Thanestada, Jirawat, et al.
Publicado: (2022)

Construction and Validation of Prognosis Nomogram for Metastatic Lung Squamous Cell Carcinoma: A Population-Based Study
por: Liu, Yuting, et al.
Publicado: (2022)

Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling
por: Wang, Shuo, et al.
Publicado: (2022)

A Realistic Breast Phantom Proposal for 3D Image Reconstruction in Digital Breast Tomosynthesis
por: Polat, Adem, et al.
Publicado: (2022)

The Clinical Research and Latest Application of Genomic Assays in Early-Stage Breast Cancer
por: Chen, Keyu, et al.
Publicado: (2022)

The Effectiveness of Population Mass Screening to Oral Cancer: A Simulation Study
por: Su, Chiu-Wen, et al.
Publicado: (2022)

Impact of Sentinel Lymph Node Biopsy on Treatment Decision and Survival in Patients Aged ≥70 Years with Breast Cancer: A Retrospective Study
por: Gu, Chongshan, et al.
Publicado: (2022)

The use of Hybrid Techniques in Whole-Breast Radiotherapy: A Systematic Review
por: Karaca, Sibel
Publicado: (2022)

Safety and Efficacy of Carbon Nanoparticle-Labeled Lymph Node Dissection in Radical Resection of Gastric Cancer: A Systematic Review and Meta-Analysis
por: Zhu, Chenglou, et al.
Publicado: (2023)

Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022)

Bronchial Artery Chemoembolization With Radiopaque Doxorubicin Eluding Beads in Patients With Malignant Hemoptysis from Metastatic Lung Cancer
por: Nezami, Nariman, et al.
Publicado: (2022)

The Applications and Potential Developments of Ultrasound in Oral Cancer Management
por: Lo, Wu-Chia, et al.
Publicado: (2022)

Cytoplasmic G Protein-Coupled Estrogen Receptor 1 as a Prognostic Indicator of Breast Cancer: A Meta-Analysis
por: Zhang, Duo, et al.
Publicado: (2022)

Tracing 2D Growth of Pancreatic Tumoroids Using the Combination of Image Processing Techniques and Mini-Opto Tomography Imaging System
por: Akbaba, Cihat Ediz, et al.
Publicado: (2023)

Antibodies Against Epstein–Barr Virus as Disease Markers of Gastric Cancer: A Systematic Review
por: Fontes-Lemus, José I., et al.
Publicado: (2023)

The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer
por: Zhang, Zaibo, et al.
Publicado: (2023)

Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
por: Yu, Limeng, et al.
Publicado: (2023)

Enrichment of Circulating Tumor Cells of Lung Cancer and Correlation With Serum Leukomonocyte and Tumor Biomarkers: A Retrospective Study
por: Mei, Zhou-Fang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vtocv58l5u50o4urp29r4s4o1c